IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)
Public ClinicalTrials.gov record NCT05989711. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Pemvidutide in Non-Cirrhotic Subjects With Nonalcoholic Steatohepatitis (NASH)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Purpose of this study is to assess the effects of pemvidutide on NASH resolution and NASH fibrosis.
Study identification
- NCT ID
- NCT05989711
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 212 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 27, 2023 (Actual)
- Primary completion
- Nov 25, 2025 (Actual)
- Completion
- Nov 25, 2025 (Actual)
- Last update posted
- May 18, 2026
2023 – 2025
United States locations
- U.S. sites
- 29
- U.S. states
- 9
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Altimmune Clinical Study Site | Chandler | Arizona | 85224 | — |
| Altimmune Clinical Study Site | Peoria | Arizona | 85345 | — |
| Altimmune Clinical Study Site | Tucson | Arizona | 85701 | — |
| Altimmune Clinial Study Site | Tucson | Arizona | 85704 | — |
| Altimmune Clinical Study Site | North Hollywood | California | 33019 | — |
| Altimmune Clinical Study Site | Panorama City | California | 91402 | — |
| Altimmune Clinical Study Site | Englewood | Colorado | 80110 | — |
| Altimmune Clinical Study Site | Bradenton | Florida | 34201 | — |
| Altimmune Clinical Study Site | Fort Myers | Florida | 33912 | — |
| Altimmune Clinical Study Site | Hialeah Gardens | Florida | 33018 | — |
| Altimmune Clinical Study Site | Miami Lakes | Florida | 33014 | — |
| Altimmune Clinical Study Site | Port Orange | Florida | 32123 | — |
| Altimmune Clinical Study Site | Sarasota | Florida | 34240 | — |
| Altimmune Clinical Study Site | West Palm Beach | Florida | 33401 | — |
| Altimmune Clinical Study Site | Dalton | Georgia | 30720 | — |
| Altimmune Clinical Study Site | Marietta | Georgia | 30006 | — |
| Altimmune Clinical Study Site | Bastrop | Louisiana | 78602 | — |
| Altimmune Clinical Study Site | Shreveport | Louisiana | 71101 | — |
| Altimmune Clinical Study Site | Clarksville | Tennessee | 37040 | — |
| Altimmune Clinical Study Site | Germantown | Tennessee | 38138 | — |
| Altimmune Clinical Study Site | Austin | Texas | 73301 | — |
| Altimmune Clinical Study Site | Bellaire | Texas | 77401 | — |
| Altimmune Clinical Study Site | Edinburg | Texas | 78539 | — |
| Altimmune Clinical Study Site | Edinburg | Texas | 78540 | — |
| Altimmune Clinical Study Site | Georgetown | Texas | 78626 | — |
| Altimmune Clinical Study Site | Houston | Texas | 77036 | — |
| Altimmune Clinical Study Site | San Antonio | Texas | 78201 | — |
| Altimmune Clinical Study Site | San Antonio | Texas | 78204 | — |
| Altimmune Clinical Study Site | West Jordan | Utah | 84081 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05989711, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 18, 2026 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05989711 live on ClinicalTrials.gov.